ArticleOncoTargets and therapy2008

Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling.

Wessen Maruwge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.